Phase I/II Study of Pre-operative Docetaxel and Mitoxantrone for High-risk Prostate Cancer

BACKGROUND: To determine the 5-year recurrence-free survival in patients with high-risk prostate cancer after neoadjuvant combination chemotherapy followed by surgery. Secondary endpoints included safety, pathologic effects of chemotherapy and predictors of disease recurrence. PATIENTS AND METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garzotto, Mark, Higano, Celestia S., O’Brien, Catherine, Rademacher, Brooks L.S., Janeba, Nicole, Fazli, Ladan, Lange, Paul H., Lieberman, Stephen, Beer, Tomasz M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2846994/
https://ncbi.nlm.nih.gov/pubmed/20143429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24960
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados